JPMorgan Chase ($JPM) Weekly Review: Defending the “Fortress”
While the market is spooked by JPM's $105 billion expense forecast, we see a "Fortress" reinforcing its walls. At $303.30, we are preparing for a Tier 2 offensive.
Mastercard ($MA) Weekly Review: Engineering the Bounce in the “Cashless” Titan
While headlines buzz about AI disrupting transaction fees, Mastercard’s revenue grew 18% YoY. At $496.03, we are officially activating the Tier 2 strike zone for this financial fortress.
Visa Inc. ($V) Weekly Review: Engineering the Bounce in a Payments Powerhouse
While the "Regulatory Reset" has spooked the market, Visa’s global toll-booth model is operating at peak efficiency. At $314.08, we are moving from Tier 1 into a heavy Tier 2 deployment.
S&P Global ($SPGI) Update: Navigating the Tier 3 “Capitulation”
The "Information Titan" just breached Tier 3. As $SPGI hits $390, we transition from observation to heavy accumulation. Here is how we manage the 60% deployment and prepare for the recovery.
Abbott Laboratories ($ABT) Weekly Review: Value in the Diversified Healthcare Titan
While the "Nutrition Reset" has rattled the market, $ABT's core MedTech engine is firing on all cylinders. At $111.07, we are officially testing the Tier 2 floor.
S&P Global ($SPGI) Weekly Review: The “Information Titan” Under Siege
S&P Global is facing its steepest selloff since 2020. As the stock slices through Tier 2 and eyes a Tier 3 entry, we separate the "AI noise" from the "Titan signal."
Paychex ($PAYX) Weekly Review: Engineering Wealth at the Tier 4 Floor
Paychex just touched our Tier 4 support level. With the stock down 40% from its high, we dive into the data to see if this is a value trap or a once-in-a-decade Resilience play.
Salesforce ($CRM) Weekly Review: Entering the Tier 5 “Resilience Threshold”
With $CRM closing at $191.35, we are staring down the Tier 5 "Resilience Threshold." Is the software-as-a-service model dead, or is this the ultimate Titan fire sale?